Package 71332-006-60

{"route": ["ORAL"], "spl_id": "af2c2115-cb7d-4679-935a-c2200487b965", "openfda": {"nui": ["N0000175605", "N0000193947"], "unii": ["1WPE73O1WV"], "rxcui": ["2394941", "2394947"], "spl_set_id": ["16edd46e-28b8-f06d-e063-6394a90ae31b"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Rearranged during Transfection (RET) Inhibitors [MoA]"], "manufacturer_name": ["Rigel Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71332-006-12)", "package_ndc": "71332-006-12", "marketing_start_date": "20240624"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71332-006-60)", "package_ndc": "71332-006-60", "marketing_start_date": "20240624"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71332-006-90)", "package_ndc": "71332-006-90", "marketing_start_date": "20240624"}], "brand_name": "Gavreto", "product_id": "71332-006_af2c2115-cb7d-4679-935a-c2200487b965", "dosage_form": "CAPSULE", "pharm_class": ["Kinase Inhibitor [EPC]", "Rearranged during Transfection (RET) Inhibitors [MoA]"], "product_ndc": "71332-006", "generic_name": "Pralsetinib", "labeler_name": "Rigel Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gavreto", "active_ingredients": [{"name": "PRALSETINIB", "strength": "100 mg/1"}], "application_number": "NDA213721", "marketing_category": "NDA", "marketing_start_date": "20240624", "listing_expiration_date": "20271231"}